Expertise at Chang Gung System

Chau-Ting Yeh , M.D.,Ph.D.
Institution: Linkou Chang Gung Memorial Hospital / Chang Gung Uiversity
Position: Director/Physician/professor
Department: Hepatology and Gastroenterology
Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.); Liver Research Center, 6J Lab
Tel: +886-3-3281200 Fax: +886-3-3285056
E-mail: chautingy@gmail.com

Focus of Interest:
  • Tissue Engineering
  • Oncology
  • Hepatitis Viruses
  • Pathology
  • Infectious Diseases
  • Medical Technology, and Clinical Pathology

Employment Records:
2001-2002 Director, Division of Hepatology, Department of GI, Chang Gung Memorial Hospital
2004-2013 Chief, Molecular biology Lab, Department of GI, Chang Gung Memorial Hospital
2007-Director, Liver Research Center, Chang Gung Memorial Hospital

Education:
1977-1984 National Taiwan University, Department of Medicine, MD
1988-1992 University of Southern California, Department of Molecular Microbiology, PhD

Honor and Awards:
Professional Award, USC graduate school; 1990
Professor Song JL’s Research Award; 1996
National Science Council Type-A Award; 1998, 1999, 2000
Distinguished Research Faculty Member, Chang Gung University 2011

Selected Publications:

1: Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, Yeh CT*. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Gastroenterology. 2012;143(2):400-7.

2: Hsu CW, Yeh CT*. Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy. Hepatology. 2011;54(1):101-8.

3: Yeh CT*, So M, Ng J, Yang HW, Chang ML, Lai MW, Chen TC, Lin CY, Yeh TS, Lee WC. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology. 2010;52(6):1922-33.

4: Hsu CW, Yeh CT*, Chang ML, Liaw YF. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. Gastroenterology. 2007;132(2):543-50.

5: Yeh CT, Chien RN, Chu CM, Liaw YF. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology. 2000;31(6):1318-26.


Full Publication List


Board Certification/Professional Affiliations:
Member, Taiwan Society of Internal Medicine
Member, The Gastroenterological Society of Taiwan
Member, The Digestive Endoscopy Society of Taiwan